Venetoclax synergizes with gilteritinib in FLT3 wild-type high-risk acute myeloid leukemia by suppressing MCL-1Maike Janssen, Sascha Dietrich, Christian Rohde et al.|Blood|2022Cited by 100
Modifiers and Readers of DNA Modifications and Their Impact on Genome Structure, Expression, and Stability in DiseaseAnne K. Ludwig, M. Cristina Cardoso|Frontiers in Genetics|2016Cited by 53